ALLOAllogene Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 11585
Ticker: ALLO
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2018-10-11
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: ALLO

Detail

Enriched 2026-08-14 20:47

Market cap: $714,469,941.27
Shares outstanding (class): 345,154,561
Shares outstanding (weighted): 345,154,561
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 152
Location: SOUTH SAN FRANCISCO, CA
Homepage: https://www.allogene.com
Description: Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).

Market cap and share counts drift.

Funds holding this security

85 funds · 88 positions · $84.91M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS	—	$13.09M	0.05%	5,364,570 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$12.72M	0.17%	5,212,606 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$11.91M	0.00%	4,879,191 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$9.36M	0.01%	3,834,951 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$9.35M	0.09%	3,830,998 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$4.59M	0.01%	1,881,862 NS	FIGI
abrdn Life Sciences Investors —	—	$3.57M	0.64%	1,462,219 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$3.32M	0.03%	1,358,691 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$2.80M	0.03%	1,145,572 NS	FIGI
College Retirement Equities Fund - Total Global… College Retirement Equities Fund	—	$2.41M	0.00%	989,626 NS	FIGI
BlackRock Health Sciences Term Trust —	—	$851.3K	0.08%	348,877 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$843.1K	0.00%	345,524 NS	FIGI
JPMorgan Small Cap Value Fund JPMorgan Trust II	—	$764.2K	0.07%	313,179 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$641.0K	0.01%	262,695 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$610.0K	0.50%	250,000 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERALLO
FIGI_COMPOSITEBBG00KHRRDX3
FIGI_SHARE_CLASSBBG00KHRRDY2
CIK0001737287
ISINUS0197701065
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Allogene Therapeutics is a clinical-stage biotech company developing CAR T-cell therapies, fitting the biotechnology industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.